Merida Biosciences

Merida Biosciences is a Cambridge, Massachusetts biopharmaceutical company developing precision immunology therapies for autoimmune and allergic disorders. The company targets the pathogenic drivers of antibody-driven diseases with the goal of durable clinical responses while minimizing the side effects of current non-specific autoimmune treatments. Launched in 2025 with $121 million in funding and backed by GV, Merida operates as a preclinical therapeutics company with a science-and-pipeline website and no public developer, API, or technical product surface.

Merida Biosciences is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Immunology, and Therapeutics.

Merida Biosciences’ developer surface includes engineering blog and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub
12.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyLife SciencesBiotechnologyImmunologyTherapeuticsAutoimmunePrecision Medicine

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 12.3/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/merida-biosciences: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 3

The organization behind the API

Website
Website
 About
About
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: merida-biosciences
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/merida-biosciences.png
name: Merida Biosciences
description: Merida Biosciences is a Cambridge, Massachusetts biopharmaceutical company developing precision immunology therapies
  for autoimmune and allergic disorders. The company targets the pathogenic drivers of antibody-driven diseases with the goal
  of durable clinical responses while minimizing the side effects of current non-specific autoimmune treatments. Launched
  in 2025 with $121 million in funding and backed by GV, Merida operates as a preclinical therapeutics company with a science-and-pipeline
  website and no public developer, API, or technical product surface.
url: https://raw.githubusercontent.com/api-evangelist/merida-biosciences/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Life Sciences
- Biotechnology
- Immunology
- Therapeutics
- Autoimmune
- Precision Medicine
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://meridabio.com
- type: About
  url: https://meridabio.com/about-us/
- type: Blog
  url: https://meridabio.com/news-media/
- type: PrivacyPolicy
  url: https://meridabio.com/privacy/
- type: TermsOfService
  url: https://meridabio.com/terms-of-use/
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 0
  pass: local-v1